{"id":"W4388182309","doi":"10.1016/j.euo.2023.10.004","title":"Olaparib plus Abiraterone for Metastatic Castration-resistant Prostate Cancer: Pharmacokinetics Data from the PROpel Trial","year":2023,"lang":"en","type":"article","venue":"European Urology Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Olaparib; Abiraterone; Medicine; Prostate cancer; Pharmacokinetics; Pharmacology; Oncology; Internal medicine; Drug; Abiraterone acetate; Urology; Cancer; Androgen deprivation therapy; Androgen receptor; Chemistry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001209828,0.000470644,0.0009166551,0.0003020001,0.0002659913,0.0007911039,0.0003640925,0.0003521253,0.003235497],"category_scores_gemma":[0.001437358,0.0002340457,0.0007308529,0.0005885987,0.0002872257,0.0004764246,0.0002756794,0.001578641,0.0004761946],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006502194,"about_ca_system_score_gemma":0.001306884,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007124851,"about_ca_topic_score_gemma":0.002427602,"domain_scores_codex":[0.9994848,0.0002238744,0.00003314994,0.00006324614,0.0001375255,0.00005747368],"domain_scores_gemma":[0.9992226,0.0002231552,0.000203958,0.0000606473,0.00009144422,0.0001981142],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.4741653,0.007181564,0.05248101,0.003270264,0.004058214,0.001451155,0.0003442443,0.007120908,0.08947948,0.0006195906,0.0196414,0.3401869],"study_design_scores_gemma":[0.4012484,0.2188241,0.2566081,0.000529331,0.003601998,0.007876121,0.0002729293,0.009021981,0.02661367,0.002003102,0.07320791,0.0001923941],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9714606,0.01387171,0.001369708,0.0008331825,0.000119847,0.001104831,0.006142065,0.0001314734,0.004966551],"genre_scores_gemma":[0.9777362,0.004320798,0.002438401,0.0009993738,0.0001730202,0.001062945,0.01108401,0.00004543652,0.002139819],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003235497,"threshold_uncertainty_score":0.01082379,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2073497634074418,"score_gpt":0.4296062803691044,"score_spread":0.2222565169616626,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}